Sanjeev Nanda, a British-Indian entrepreneur based in Dubai has invested in ISHVAN Pharmaceuticals Ltd to develop the pharmaceutical infrastructure of Russia. The company will focus on bringing in inexpensive and innovative medical drugs and devices to new pharmaceutical markets. Cipla, Laurus, and Myla are some of the Indian companies that have entered into negotiations with ISHVAN for this initiative.
Subscribe to:
Post Comments (Atom)
-
Sachin Dev Duggal and his college mate Saurav Dhoot. Duggal, a serial entrepreneur, holds an engineering degree from Imperial College, L...
-
Darren Huston is an alumnus of the UWC Adriatic 1983–1985 visited the college and gave a lecture. When Darren Huston was talking about his...
-
President and CEO of The Priceline Group, Darren Huston , says there is no negative impact on the company's financial performance as...
No comments:
Post a Comment